Stocks Overview

LAST PRICE
0.8485
TODAY'S CHANGE (%)
Trending Up0.0113 (1.3497%)

Bid / Lots
0.8475/ 69
Ask / Lots
0.8570/ 15
Open / Previous Close
0.8500 / 0.8372
Day Range
Low 0.8300
High 0.8646
52 Week Range
Low 0.5400
High 2.1100
Volume
2,160,572
below average

Search Criteria

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
Company	Country	Symbol

TSX Comp
TSX Venture
DJIA
S&P 500
NASDAQ

Price Comparison Graph. See accessible table below

1 Day Comparison Chart Accessibility Table. Thursday's close: 0.8372
Time	Volume	MCRB
09:32 ET	35343	0.85
09:34 ET	24497	0.8492
09:36 ET	5134	0.849499
09:38 ET	33300	0.85
09:39 ET	4038	0.8475
09:41 ET	10170	0.842551
09:43 ET	1000	0.847475
09:45 ET	35605	0.8401
09:50 ET	4384	0.8499
09:52 ET	1500	0.845
09:54 ET	5000	0.844899
09:56 ET	40657	0.8385
09:57 ET	100	0.8385
09:59 ET	88937	0.8385
10:01 ET	50161	0.8319
10:03 ET	11125	0.832
10:06 ET	5400	0.8342
10:08 ET	500	0.8452
10:10 ET	9638	0.841
10:12 ET	17621	0.836
10:14 ET	1100	0.8361
10:15 ET	2400	0.8428
10:17 ET	182359	0.851
10:19 ET	13890	0.8554
10:21 ET	700	0.8555
10:24 ET	4718	0.8526
10:26 ET	63483	0.8549
10:28 ET	28820	0.8435
10:30 ET	2307	0.8489
10:32 ET	1300	0.843
10:33 ET	16786	0.84574
10:35 ET	1625	0.8463
10:37 ET	290	0.848178
10:39 ET	1000	0.849
10:42 ET	300	0.846
10:44 ET	1400	0.8489
10:46 ET	400	0.849
10:48 ET	335	0.8487
10:50 ET	100	0.8449
10:51 ET	100	0.845
10:53 ET	1631	0.8494
10:55 ET	200	0.8513
10:57 ET	18000	0.8526
11:00 ET	351	0.8551
11:02 ET	958	0.8569
11:04 ET	300	0.8572
11:06 ET	75358	0.858088
11:08 ET	3634	0.86375
11:09 ET	7177	0.8601
11:11 ET	1163	0.86
11:13 ET	408	0.86
11:15 ET	1700	0.857
11:18 ET	19725	0.8555
11:20 ET	2380	0.8588
11:22 ET	23100	0.8571
11:24 ET	56589	0.8598
11:26 ET	9224	0.8589
11:27 ET	8302	0.849
11:31 ET	42416	0.8474
11:33 ET	6235	0.8409
11:36 ET	5564	0.845
11:38 ET	1500	0.8449
11:40 ET	855	0.8449
11:42 ET	1227	0.8435
11:44 ET	15000	0.8459
11:45 ET	2615	0.845
11:47 ET	1668	0.8465
11:49 ET	3854	0.8458
11:54 ET	100	0.844
11:56 ET	8200	0.8443
11:58 ET	7606	0.8463
12:00 ET	6309	0.8452
12:02 ET	5998	0.8456
12:03 ET	2183	0.846
12:05 ET	300	0.8461
12:07 ET	500	0.8476
12:09 ET	891	0.8476
12:12 ET	661	0.8466
12:14 ET	300	0.8478
12:16 ET	501	0.8478
12:18 ET	12924	0.8489
12:20 ET	12775	0.8518
12:21 ET	200	0.8519
12:23 ET	671	0.8519
12:25 ET	45441	0.8531
12:27 ET	18500	0.8531
12:30 ET	738	0.8501
12:32 ET	2180	0.8514
12:34 ET	7310	0.844
12:36 ET	100	0.844
12:38 ET	4014	0.852
12:39 ET	2000	0.85395
12:41 ET	15000	0.8577
12:43 ET	6100	0.8505
12:45 ET	49565	0.8558
12:48 ET	100	0.8521
12:50 ET	1799	0.8573
12:52 ET	23150	0.8573
12:54 ET	16151	0.8558
12:56 ET	2916	0.856
12:57 ET	4148	0.8547
12:59 ET	1550	0.85525
01:01 ET	1200	0.8533
01:03 ET	100	0.8507
01:06 ET	800	0.8555
01:08 ET	714	0.8558
01:10 ET	200	0.8556
01:12 ET	3957	0.8516
01:14 ET	25719	0.8516
01:15 ET	100	0.8505
01:17 ET	6556	0.8535
01:21 ET	8650	0.8533
01:24 ET	2041	0.8518
01:26 ET	2537	0.8534
01:28 ET	15595	0.8542
01:30 ET	30308	0.8566
01:32 ET	117313	0.8519
01:35 ET	252	0.8518
01:39 ET	791	0.8446
01:42 ET	400	0.8484
01:44 ET	8571	0.8484
01:46 ET	1000	0.8508
01:48 ET	798	0.8494
01:50 ET	200	0.852
01:51 ET	5610	0.852
01:53 ET	1220	0.8517
01:55 ET	13292	0.8517
01:57 ET	9580	0.8484
02:02 ET	796	0.8476
02:04 ET	57528	0.8479
02:06 ET	15611	0.8479
02:08 ET	300	0.8478
02:09 ET	5100	0.844
02:11 ET	332	0.844
02:13 ET	10400	0.8459
02:15 ET	5268	0.8445
02:18 ET	100	0.8445
02:20 ET	15545	0.8412
02:22 ET	640	0.8451
02:24 ET	1010	0.8454
02:26 ET	2227	0.8462
02:27 ET	2071	0.8474
02:31 ET	5200	0.848
02:33 ET	3437	0.8503
02:36 ET	1660	0.8507
02:38 ET	200	0.8471
02:40 ET	100	0.8494
02:42 ET	2789	0.85
02:44 ET	589	0.8497
02:45 ET	504	0.85
02:49 ET	5850	0.8464
02:51 ET	400	0.8497
02:54 ET	1521	0.8477
02:56 ET	1673	0.846
02:58 ET	1818	0.8503
03:00 ET	100	0.848
03:02 ET	1666	0.8473
03:03 ET	1234	0.8471
03:05 ET	6802	0.8517
03:07 ET	11500	0.8494
03:09 ET	100	0.84945
03:12 ET	5364	0.8496
03:14 ET	2467	0.8519
03:16 ET	633	0.8501
03:18 ET	1539	0.850001
03:20 ET	656	0.85
03:21 ET	1000	0.852
03:23 ET	8000	0.8502
03:25 ET	2727	0.8503
03:27 ET	12831	0.8489
03:30 ET	507	0.8488
03:32 ET	1198	0.8502
03:34 ET	2305	0.8503
03:36 ET	3700	0.8488
03:38 ET	1000	0.84945
03:39 ET	41452	0.8516
03:41 ET	9915	0.85315
03:43 ET	5037	0.8532
03:45 ET	1580	0.8522
03:48 ET	7119	0.8541
03:50 ET	105709	0.8508
03:52 ET	14760	0.8487
03:54 ET	14302	0.8522
03:56 ET	13278	0.85155
03:57 ET	17438	0.8531
03:59 ET	93252	0.8485

Data delayed at least 15 minutes.

Sep 30, 2024
- Seres Therapeutics Announces Completion of VOWST(TM) Asset Sale to Soci t des Produits Nestl S.A, from 5:15PM ET on Monday Sep 30, 2024 by Dow Jones
  5:15PM ET on Monday Sep 30, 2024 by Dow Jones
Sep 26, 2024
- Seres Therapeutics Stockholders Approve Sale of VOWST(TM) to Nestl Health Science; Sale Expected to Close on September 30, from 4:01PM ET on Thursday Sep 26, 2024 by Dow Jones
  4:01PM ET on Thursday Sep 26, 2024 by Dow Jones
Sep 13, 2024
- DJ Seres Therapeutics Is Maintained at Buy by Canaccord Genuity, from 2:48PM ET on Friday Sep 13, 2024 by Dow Jones
  2:48PM ET on Friday Sep 13, 2024 by Dow Jones
- Seres Therapeutics to Participate in Cantor 2024 Global Healthcare Conference, from 7:00AM ET on Friday Sep 13, 2024 by Dow Jones
  7:00AM ET on Friday Sep 13, 2024 by Dow Jones
Sep 12, 2024
- Seres Therapeutics Reports SER-155 Phase 1b Placebo-Controlled Cohort 2 Study Safety and Clinical Results in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplant (allo-HSCT), from 7:00AM ET on Thursday Sep 12, 2024 by Dow Jones
  7:00AM ET on Thursday Sep 12, 2024 by Dow Jones

0 New Today

Industry Peers Overview Table
Company sortable	Market Cap sortable	P/E Ratio (TTM) sortable	EPS Growth (5yr) sortable
United StatesMCRB Seres Therapeutics Inc	129.3M	-0.7x	---
United StatesKPTI Karyopharm Therapeutics Inc	110.6M	-1.1x	---
United StatesHRTX Heron Therapeutics Inc	321.5M	-6.5x	---
United StatesCTMX CytomX Therapeutics Inc	89.8M	8.4x	---
United StatesSPRO Spero Therapeutics Inc	70.3M	4.1x	---
United StatesAGEN Agenus Inc	105.1M	-0.4x	---
As of 2024-10-06

Seres Therapeutics, Inc. is a clinical-stage company focused on improving patient outcomes in medically vulnerable populations through novel live biotherapeutics. The Company is engaged in developing SER-155, which has demonstrated a significant reduction in bloodstream infections and related complications (as compared to placebo) in a clinical study in patients undergoing allogeneic Hematopoietic Stem Cell Transplantation (allo-HSCT). The Company is also advancing additional cultivated oral live biotherapeutics for medically vulnerable populations, including those with chronic liver disease, cancer neutropenia, and solid organ transplants. The Company's clinical and nonclinical data across its programs support the development of live biotherapeutics to target the prevention and treatment of a broad swath of infections, and in inflammatory and immune diseases.

Contact Information

Headquarters: 101 Cambridge Park DriveCAMBRIDGE, MA, United States 02140
Phone: 617-945-9626
Fax: 302-655-5049

Executives

Independent Chairman of the Board: Stephen Berenson
President, Chief Executive Officer, Director: Eric Shaff
Chief Financial Officer, Executive Vice President: Marella Thorell
Executive Vice President, Chief Technology Officer: David Ege
Executive Vice President, Chief Scientific Officer: Matthew Henn

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Skip section

INK Company InsiderDetailed daily analysis of insider activity and holdings for stocks and income trusts listed in Canada, based on filings from SEDI®.

Fundamentals Table
Market Cap	$129.3M
Revenue (TTM)	$374.0K
Shares Outstanding	152.4M
Dividend Yield	0.00%
Annual Dividend Rate	---
Ex-Dividend Date	01-01-01
Pay Date	01-01-01
Beta	2.04
EPS	$-1.18
Book Value	$-0.33
P/E Ratio	-0.7x
Price/Sales (TTM)	345.7
Price/Cash Flow (TTM)	---
Operating Margin	-42,211.23%

*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.

Seres Therapeutics Inc
NASDAQ:MCRBUnited States

Search Criteria

Charts

Recent News

Sep 30, 2024

Seres Therapeutics Announces Completion of VOWST(TM) Asset Sale to Soci t des Produits Nestl S.A, from 5:15PM ET on Monday Sep 30, 2024 by Dow Jones

Sep 26, 2024

Seres Therapeutics Stockholders Approve Sale of VOWST(TM) to Nestl Health Science; Sale Expected to Close on September 30, from 4:01PM ET on Thursday Sep 26, 2024 by Dow Jones

Sep 13, 2024

DJ Seres Therapeutics Is Maintained at Buy by Canaccord Genuity, from 2:48PM ET on Friday Sep 13, 2024 by Dow Jones

Seres Therapeutics to Participate in Cantor 2024 Global Healthcare Conference, from 7:00AM ET on Friday Sep 13, 2024 by Dow Jones

Sep 12, 2024

Seres Therapeutics Reports SER-155 Phase 1b Placebo-Controlled Cohort 2 Study Safety and Clinical Results in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplant (allo-HSCT), from 7:00AM ET on Thursday Sep 12, 2024 by Dow Jones

Biotechnology Industry Peers

Company Information

Contact Information

Executives

Ratings

Reports

Fundamentals

Calendar